These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3584763)

  • 21. Seropositivity of influenza A H1NI in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic.
    Chao AS; Chang YL; Chao A; Wu TS; Yang LY; Lian R; Huang YC
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):37-40. PubMed ID: 28254223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
    Frey SE; Bernstein DI; Brady RC; Keitel WA; El Sahly H; Rouphael NG; Mulligan MJ; Atmar RL; Edupuganti S; Patel SM; Dickey M; Graham I; Anderson EL; Noah DL; Hill H; Wolff M; Belshe RB
    Vaccine; 2015 Jan; 33(1):163-73. PubMed ID: 25444805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    Petrie JG; Ohmit SE; Truscon R; Johnson E; Braun TM; Levine MZ; Eichelberger MC; Monto AS
    J Infect Dis; 2016 Oct; 214(8):1142-9. PubMed ID: 27095420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
    Lambkin-Williams R; Gelder C; Broughton R; Mallett CP; Gilbert AS; Mann A; He D; Oxford JS; Burt D
    PLoS One; 2016; 11(12):e0163089. PubMed ID: 28005959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
    Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
    Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial.
    Hartvickson R; Cruz M; Ervin J; Brandon D; Forleo-Neto E; Dagnew AF; Chandra R; Lindert K; Mateen AA
    Int J Infect Dis; 2015 Dec; 41():65-72. PubMed ID: 26585940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly.
    Kao TM; Hsieh SM; Kung HC; Lee YC; Huang KC; Huang LM; Chang FY; Wang NC; Liu YC; Lee WS; Liu HE; Chen CI; Chen CH
    Vaccine; 2010 Aug; 28(38):6159-63. PubMed ID: 20659517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of Influenza Vaccination in Patients With Cancer.
    Waqar SN; Boehmer L; Morgensztern D; Wang-Gillam A; Sorscher S; Lawrence S; Gao F; Guebert K; Williams K; Govindan R
    Am J Clin Oncol; 2018 Mar; 41(3):248-253. PubMed ID: 26669741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulating effect of influenza vaccination in the elderly differing in health status.
    Myśliwska J; Trzonkowski P; Szmit E; Brydak LB; Machała M; Myśliwski A
    Exp Gerontol; 2004 Oct; 39(10):1447-58. PubMed ID: 15501014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak.
    Gravenstein S; Drinka P; Duthie EH; Miller BA; Brown CS; Hensley M; Circo R; Langer E; Ershler WB
    J Am Geriatr Soc; 1994 Mar; 42(3):245-51. PubMed ID: 8120307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status.
    Hara M; Tanaka K; Hirota Y
    Vaccine; 2005 Feb; 23(12):1457-63. PubMed ID: 15670881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population.
    Atsmon J; Caraco Y; Ziv-Sefer S; Shaikevich D; Abramov E; Volokhov I; Bruzil S; Haima KY; Gottlieb T; Ben-Yedidia T
    Vaccine; 2014 Oct; 32(44):5816-23. PubMed ID: 25173483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.
    Huang KA; Chang SC; Huang YC; Chiu CH; Lin TY
    Sci Rep; 2017 Jan; 7():40027. PubMed ID: 28098157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response to influenza vaccine in adult liver transplant recipients.
    Duchini A; Hendry RM; Nyberg LM; Viernes ME; Pockros PJ
    Liver Transpl; 2001 Apr; 7(4):311-3. PubMed ID: 11303290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.
    Van der Vliet D; Pepin S; Lambert M; Fauchoux N; Donazzolo Y; Dupuy M; Dakowski C; Denis M
    Hum Vaccin; 2010 Oct; 6(10):823-8. PubMed ID: 20935517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S; Nauta J; Montomoli E; Weckx J
    Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.